Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
SS Pharmaceutical Co., Ltd. Patents
Assignee:
SS Pharmaceutical Co., Ltd.
Address:
Tokyo, JP
No. of patents:
89
Patents:


1 2










Patent Number Title Of Patent Date Issued
6174900 Substituted piperidine derivative for treating urinary disturbance January 16, 2001
Disclosed herein is a substituted piperidine derivative represented by the following general formula (1): ##STR1##wherein R.sup.1 means an aryl or heteroaryl group which may have at least one substituent, R.sup.2 denotes an alkyl, alkenyl or aralkyl group, R.sup.3 stands for a hydrog
6171520 Reagents for labeling SH groups, process for the preparation of them and method for labeling wit January 9, 2001
Disclosed are SH-labeling reagents containing acridine compounds represented by the following formula (I): ##STR1##whereinA represents the following group:orin which Q represents a group --S.sup.+ RX.sup.- --, a group --N.sup.+ RR.sub.1 X.sup.- -- wherein R.sub.1 represents an alkyl grou
6103538 Colloidal gold immunoassay method August 15, 2000
Disclosed herein is a method for the detection of a target substance by a colloidal gold immunoassay, which comprises dissolving in an immunoreaction system a metal salt selected from the group consisting of sodium, potassium and lithium fluorides, sodium, potassium, lithium and magn
6063945 Triazole derivative or salt thereof May 16, 2000
A compound having formula (2): ##STR1## wherein R represents hydrogen, a straight or branched C.sub.1-10 alkyl group, a C.sub.7-11 aralkyl group or a C.sub.2-10 carboacyl group and m stands for 1 to 5.
6046218 Pyridine derivative and medicament containing the same as an effective ingredient April 4, 2000
Described is a pyridine derivative represented by the following formula (1): ##STR1## wherein R.sup.1 and R.sup.2 individually represent H, an alkyl group, a cycloalkyl group, a hydroxyalkyl group, an alkoxyalkyl group which may have a substituent, a carboxyalkyl group, an alkoxy
6002028 Triazole derivative, preparation process thereof and pharmaceutical comprising the same as an ef December 14, 1999
Described is a triazole derivative represented by the formula (1) or salt thereof, preparation process thereof, preparation intermediates represented by the formulas (2) and (3), and a pharmaceutical comprising the compound represented by the formula (1) or salt thereof. ##STR1##
5986144 Triazole derivative, preparation process thereof and pharmaceutical comprising the same as an ef November 16, 1999
Described is a triazole derivative represented by the formula (1) or salt thereof, preparation process thereof, preparation intermediates represented by the formulas (2) and (3), and a pharmaceutical comprising the compound represented by the formula (1) or salt thereof. wherein n st
5968956 Substituted piperidine derivative and medicine comprising the same October 19, 1999
Disclosed herein is a substituted piperidine derivative represented by the following general formula (1): ##STR1## wherein R.sup.1 means an aryl or heteroaryl group which may have at least one substituent, R.sup.2 denotes an alkyl, alkenyl or aralkyl group, R.sup.3 stands for a h
5945438 Triazole derivative and pharmaceutical comprising the same as an effective ingredient August 31, 1999
Described is a triazole derivative represented by the formula (1) or salt thereof, preparation process thereof, preparation intermediates represented by the formulas (2) and (3), and a pharmaceutical comprising the compound represented by the formula (1) or salt thereof. ##STR1##
5939448 Triazole derivative or salt thereof August 17, 1999
Described is a triazole derivative represented by the formula (1): wherein R represents a hydrogen atom, an alkyl group, an aralkyl group or an acyl group, n stands for 0 to 2 and m stands for 1 to 5 or salt thereof, and a pharmaceutical containing the derivative or salt as an effective
5935977 Substituted vinyl pyridine derivative and drugs containing the same August 10, 1999
The present invention relates to a substituted vinylpyridine derivative represented by the following formula (1): ##STR1## (wherein R.sup.1 represents a hydrogen atom, an alkyl group, etc., R.sup.2 represents an alkyl group; one of R.sup.3 and R.sup.4, which are different from ea
5922767 Substituted benzylurea derivatives and medicine containing the same July 13, 1999
Disclosed herein are substituted benzylurea derivatives represented by the following general formula (1): ##STR1## wherein R.sup.1 and R.sup.2 are independently H, a halogen atom, or an alkyl or alkoxyl group, R.sup.3 is a phenyl or heterocyclic group which may be substituted, n
5902826 Platinum (IV) complex and pharmaceutical composition comprising the same May 11, 1999
A diamine-platinum (IV) complex represented by the following formula (1): ##STR1## wherein R.sup.1 and R.sup.2 together represent R.sup.5 O--CH(CH.sub.2 NH.sub.2).sub.2 (R.sup.5 represents hydrogen, acetyl, trifluoroacetyl, benzoyl, cycloalkylcarbonyl or methanesulfonyl) or a C.sub.5
5866609 Substituted vinylurea derivatives and medicine containing the same February 2, 1999
Disclosed herein are substituted vinylurea derivatives represented by the following general formula (1): ##STR1## wherein R.sup.1 and R.sup.3 are independently a phenyl group which may be substituted, R.sup.2 is a phenyl group which may be substituted, or a cycloalkyl group, and
5789419 4-quinolinone derivative or salt thereof August 4, 1998
This invention relates to a 4-quinolinone derivative represented by the following general formula (1): ##STR1## wherein R.sup.1 and R.sup.2 mean individually H, halogen, cyano, or lower alkyl, lower alkylsulfonyl, lower alkylsulfinyl, lower alkylthio or lower alkoxy which may be
5710152 Benzoazine derivative or salt thereof and pharmaceutical compostion comprising the same January 20, 1998
A benzoazine derivative represented by the following formula (1), ##STR1## wherein R.sup.1 represents an alkyl group, alkoxy group, halogen atom, halogenoalkyl group, amino group, hydroxy group, benzyloxy group which may have a substituent, cyano group, carbamoyl group, acyl group, n
5707878 Method for detecting blood component using conidiobolus hemagglutinin January 13, 1998
A method for detecting blood component in a sample comprising reacting a human erythrocyte membrane band 3 glycoprotein (band 3) in the sample and a hemagglutinin produced by a microorganism belonging to the genus Conidiobolus (CA) and measuring said band 3 glycoprotein contained in a
5676970 Anti-inflammatory analgesic plaster October 14, 1997
An anti-inflammatory analgesic plaster carries thereon a base which comprises piroxicam and a polyoxyethylene nonionic surfactant having 5-15 moles of added ethylene oxide.
5654002 Piroxicam tablets and production and process thereof August 5, 1997
A process is provided for the production of piroxicam tablets. According to the process, a solution of a water-soluble high-molecular substance is added to a mixture of piroxicam and lactose. The resultant mixture is granulated and then compressed into tablets.
5585511 Platinum complex and malignant tumor treating drug containing the same December 17, 1996
A platinum complex represented by the following formula (1): ##STR1## wherein the all symbols are defined in the disclosure; and a malignant tumor treating drug which contains the complex as an active ingredient. The platinum complex is excellent in antitumor effects and safety and i
5578600 Stable liquid preparation of complex vitamin for internal use November 26, 1996
Described is a stable liquid preparation of complex vitamin for internal use. The preparation containing vitamin B.sub.1 and vitamin B.sub.12, and as a sweetening agent, a sugar alcohol. The pH of the preparation has been adjusted to 3.5 to 4.5.
5532371 Piperazine substituted carboxylic acid derivatives for treating hyperlipimia July 2, 1996
An arylamide derivative of formula (1), a salt thereof and a therapeutic agent for hyperlipemia which comprises the derivative or salt: ##STR1## wherein Ar represents a group ##STR2## a naphthyl group, a pyridinyl group, a furyl group, a thienyl group, a quinolyl group or an
5500221 Sustained release suppository March 19, 1996
The present invention relates to a sustained-release suppository preparation characterized by comprising an acidic drug or a salt thereof which can be absorbed by rectal administration and an acidic compound or a pH buffering agent. The sustained-release suppository preparation of the
5498780 Platinum complex and malignant tumor treating drug containing the same March 12, 1996
A diamine-platinum complex represented by the following formula (1): ##STR1## wherein the all definitions are defined in the disclosure, and a malignant tumor treating drug which contains the above complex as an active ingredient. The diamine-platinum complex has a high water solubil
5496819 Antiphlogistic-analgesic plaster comprising triacetin and piroxicam March 5, 1996
An antiphlogistic-analgesic plaster comprising piroxicam and triacetin and/or triethyl citrate.The antiphlogistic-analgesic plaster of the invention is excellent in percutaneous absorption of piroxicam and hence has an excellent antiphlogistic and analgesic effect.
5496561 Controlled release-initiation and controlled release-rate pharmaceutical composition March 5, 1996
A controlled release-initiation and controlled release-rate pharmaceutical composition in which a drug-containing composition is coated with a membrane layer comprising a water insoluble high polymer and silicone. The starting time for the release of drugs from the controlled release
5447926 Quinolone carboxylic acid derivatives September 5, 1995
A quinolone carboxylic acid derivative having the following formula (1), ##STR1## wherein R.sup.1 is a hydrogen atom, an alkyl group, an aralkyl group, an ester residual group which can be hydrolyzed in living bodies, R.sup.2 is a hydrogen atom or an amino group which may be substitu
5440036 1,4-benzoxazine derivatives August 8, 1995
A 1,4-benzoxazine derivative represented by the following formula (1): ##STR1## wherein R.sup.1 represents an unsubstituted or halogen-substituted lower alkyl, unsubstituted or halogen-substituted lower alkylsulfonyl, nitro or cyano group, R.sup.2 and R.sup.3 may be the same or diffe
5430028 5-aminoquinolone carboxylic acid derivative and antibacterial agent containing the same as activ July 4, 1995
A 5-aminoquinolone carboxylic acid derivative represented by the following general formula (1): ##STR1## wherein R.sup.1 means a hydrogen atom, an amino group, a linear or branched alkyl group having 1-5 carbon atoms and an alkylamino group containing a linear or branched alkyl g
5422102 Antiinflammatory and analgesic gel preparation June 6, 1995
An antiinflammatory and analgesic gel preparation comprising diclofenac or its salts, an ester of dibasic acid, a lower alcohol, and a nonionic polymer or a mixture of nonionic polymers selected from the group consisting of (a) 1.5-4% by weight of hydroxypropyl cellulose having a mol
5411972 Arylamide derivatives for treating hyperlipemia May 2, 1995
An arylamide derivative of formula (1), a salt thereof and a therapeutic agent for hyperlipemia which comprises the derivative or salt: ##STR1## wherein Ar represents a group ##STR2## a naphthyl group, a pyridinyl group, a furyl group, a thienyl group, a quinolyl group or an
5405840 Pranoprofen-containing, suspending medicinal composition April 11, 1995
A pranoprofen-containing, suspending medicinal composition is formed of the following three ingredients (a) to (c):(a) pranoprofen;(b) a suspending agent comprising microcrystalline cellulose-sodium carboxymethylcellulose, sodium carboxymethylcellulose and hydroxypropyl methylcellulose;
5385900 Quinoline carboxylic acid derivatives January 31, 1995
A quinolone carboxylic acid derivative having the following formula (1), ##STR1## wherein R.sup.1 is a hydrogen atom, an alkyl group, an aralkyl group, an ester residual group which can be hydrolyzed in living bodies, R.sup.2 is a hydrogen atom or an amino group which may be substitu
5350769 Antiinflammatory gel preparation September 27, 1994
The present invention relates to an antiinflammatory gel preparation comprising an ammonium or sodium salt of diclofenac, a nonionic polymer, a dibasic ester, and a lower alcohol. The gel preparation of the present invention exhibits superior percutaneous absorptivity, thus providing
5348744 Antidiarrheal compositions containing loperamide hydrochloride and a saccharide September 20, 1994
Described herein are antidiarrheal compositions containing loperamide hydrochloride as an effective ingredient and a saccharide, for example, a monosaccharide, oligosaccharide or sugar alcohol in an amount as much as at least 3,000 times the weight of loperamide hydrochloride.
5324735 Quinoline carboxylic acid derivatives June 28, 1994
The present invention relates to a quinolone carboxylic acid derivative represented by the following the formula (I), ##STR1## wherein R.sub.1 is a lower alkyl group, R.sub.2 is a hydrogen atom or a lower alkyl group, R.sub.3 is a hydrogen atom or a halogen atom, R.sub.4 and R.su
5300517 Piperidine compounds having anti-acetylcholinesterase activity April 5, 1994
Piperidine compounds of formula II: ##STR1## that exhibit anticholinesterase activity and are effective in treating dementia.
5275825 Compressed-molded preparations January 4, 1994
Compressed molded preparations are disclosed. In the preparation coated granules of a pharmaceutical composition are compressed and molded together with non-coated component(s) containing 10% or more by weight of non-swelling polymers. According to the preparation there is little bre
5258375 Composition for the preparation of dosage-form active vitamins D.sub.3 containing polyvinylaceta November 2, 1993
Compositions suitable for use in the preparation of dosage-form active vitamins D.sub.3 are disclosed. Each composition comprises an active vitamin D.sub.3 and a stabilizer selected from polyvinylacetal diethylaminoacetate and hydroxypropylcellulose. Also disclosed are processes for
5240934 Quinoline derivatives August 31, 1993
Quinoline derivatives of the formula, ##STR1## wherein >A represents a group >N--(CH.sub.2).sub.n --, >C.dbd., >C.dbd.CH(CH.sub.2).sub.n --, or >CH(CH.sub.2).sub.n --, wherein n is an integer of 0-7; Y represents a group >C.dbd.O or >CHOH, R.sup.1 is a hydrog
5231101 Benzo[5,6]cyclohepta[1,2-B]pyridine derivatives and antiallergic agents comprising same July 27, 1993
Benzo[5,6]cyclohepta[1,2-b]pyridine derivatives of the following formula: ##STR1## wherein R.sup.1 represents a cyano, carbamoyl, alkylsulfoxy, alkylsulfonyl, tetrazolyl or sulfonic acid group, and R.sup.2 represents a hydrogen atom, a cyano, phenyl, aralkyl, alkoxycarbonylalkyl,
5225206 Sustained-release pranoprofen preparation July 6, 1993
A sustained-release pranoprofen preparation is disclosed. The preparation comprises an effective amount of pranoprofen and one or more sustained-release components selected from the group consisting of oily components, water-soluble components, water-insoluble components, and intesti
5208035 Diclofenac sodium plaster May 4, 1993
A diclofenac sodium plaster has a backing material and a paste spread on the backing material. The paste is composed of diclofenac sodium, a penetration enhancer composed of 1-menthol and propylene glycol, and a hydrophilic base composed principally of a water-soluble polymer.
5204087 Composition for foaming preparation April 20, 1993
A composition for foaming preparation comprising (a) an organic acid of which the crystal surface is coated with a sugar and (b) a carbonate is disclosed. In the composition, an organic acid is completely shut off from a carbonate by a sugar coating so that the acid does not react with t
5190951 Quinoline derivatives March 2, 1993
Quinoline derivatives of the formula, ##STR1## wherein > A represents a group >N--(CH.sub.2).sub.n --, >C.dbd., >C.dbd.CH(CH.sub.2).sub.n --, or >CH(CH.sub.2).sub.n --, wherein n is an integer of 0-7; Y represents a group >C.dbd.O or >CHOH, R.sup.1 is a hydro
5186943 Compressed-molded preparations February 16, 1993
Compressed-molded preparations are disclosed. In the preparation coated granules of a pharmaceutical composition are compressed and molded together with non-coated component(s) containing 10% or more by weight of non-swelling polymers. According to the preparation there is little bre
5182112 Antidiarrheal compositions containing laperamide hydrochloride and a saccharide January 26, 1993
Described herein are antidirarrheal compositions containing loperamide hydrochloride as an effective ingredient and a saccharide, for example, a monosaccharide, oligosaccharide or sugar alcohol in an amount as much as at least 3,000 times the weight of loperamide hydrochloride.
5164513 Imidazole derivative November 17, 1992
Novel imidazole derivatives and their acid adducts are disclosed. The imidazole derivatives are represented by formula: ##STR1## wherein R.sub.1 represents an alkyl group, R.sub.2 represents a hydrogen atom, an alkyl group which may have a substituent, or an aralkyl group which m
5164193 Sustained-release tablet November 17, 1992
A sustained-release tablet is disclosed. The tablet is a combination of powder (A) comprising an oil component, water insoluble polymer, or both, and a pharmaceutically active component and powder (B) comprising a water soluble polymer and a pharmaceutically active component. An ideal re
5159091 Process for preparing 21-desoxyprednisolone 17-esters October 27, 1992
A process for preparing 21-desoxyprednisolone 17-esters of formula (IV) is disclosed. ##STR1## The process comprises reacting a prednisolone 17.alpha.,21-cyclic orthoester with an acid in a 40-60% lower alcohol solution to produce a prednisolone 17-ester, sulfonylating the predni
1 2

 
 
  Recently Added Patents
Liquid crystal display apparatus
Data processing method
Stabilized redispersible polymer powder compositions
Nuclear fuel assembly bottom nozzle
Lacrosse head
Fluid handling structure, a lithographic apparatus and a device manufacturing method
Piperazinedione compounds
  Randomly Featured Patents
Quasi-optical gyrotron
Display screen with animated graphical user interface
Method for forming a tensile plasma enhanced nitride capping layer over a gate electrode
Semiconductor power device with shear stress compensation
Handheld computing device
Information displaying apparatus with word searching function and recording medium
Method and apparatus for measuring a concentration of a component in a subject
Method manipulating a delivery system using expiring indicia
Cam target wheel for vehicle
Method and apparatus for adaptive memory cell overerase compensation